Clinical Trial Update: Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for nonmyeloablative conditioning and transplantation in refractory systemic lupus erythematosus (SLE) has terminated; results posted in 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease
• Systemic Lupus Erythematosus

Snippet

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | Conditions: Lupus Erythematosus, Graft-versus-host Disease | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2018-10-02